Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Brand names such as Ozempic, Wegovy, Mounjaro, and Zepbound have become part of the cultural conversation, each representing a variation of this powerful therapeutic approach
Shots generally offer higher bioavailability
A practitioner asking should I offer MIC? in 2026 is implicitly asking why would I, when I can prescribe a GLP-1? The honest answers are narrower than the marketing, but they are real: Patients who cannot or will not take a GLP-1
Obesity is an alarmingly common chronic weight gain disorder characterized by excessive fat deposition that often increases the risk of type 2 diabetes (T2D) and cardiovascular diseases (CVD)
DPP-4 Inhibitors: Drugs like sitagliptin and linagliptin are DPP-4 inhibitors
Unlike Mounjaro (tirzepatide), which works on two different hormone receptors, Wegovy works on just one (GLP-1)
US$ 29.41
US$ 27.61
US$ 24.51
US$ 24.45
US$ 28.86
